First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
- Status
- TERMINATED
- Phase
- PHASE2
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
- Status
- TERMINATED
- Phase
- PHASE3
Japanese Phase 1 Multiple Ascending Dose Study
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
- Status
- TERMINATED
- Phase
- PHASE2
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
- Status
- COMPLETED
- Phase
- PHASE3
Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects
- Status
- COMPLETED
- Phase
- N/A
Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores
- Status
- COMPLETED
- Phase
- NA
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
- Status
- COMPLETED
- Phase
- N/A
Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive
- Status
- TERMINATED
- Phase
- PHASE2
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2